PRAH - PRA Health Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.05B
Enterprise Value 38.45B
Trailing P/E 30.92
Forward P/E 119.23
PEG Ratio (5 yr expected) 11.51
Price/Sales (ttm)2.35
Price/Book (mrq)7.45
Enterprise Value/Revenue 32.82
Enterprise Value/EBITDA 617.69

Trading Information

Stock Price History

Beta (5Y Monthly) 1.11
52-Week Change 3-2.40%
S&P500 52-Week Change 321.03%
52 Week High 3115.50
52 Week Low 385.00
50-Day Moving Average 3106.74
200-Day Moving Average 3102.76

Share Statistics

Avg Vol (3 month) 3487.64k
Avg Vol (10 day) 3351.18k
Shares Outstanding 563.25M
Float 63.11M
% Held by Insiders 10.20%
% Held by Institutions 1101.93%
Shares Short (Jan 30, 2020) 42.38M
Short Ratio (Jan 30, 2020) 44.91
Short % of Float (Jan 30, 2020) 44.05%
Short % of Shares Outstanding (Jan 30, 2020) 43.77%
Shares Short (prior month Dec 30, 2019) 42.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 8.00%
Operating Margin (ttm)12.15%

Management Effectiveness

Return on Assets (ttm)6.74%
Return on Equity (ttm)24.85%

Income Statement

Revenue (ttm)3B
Revenue Per Share (ttm)46.07
Quarterly Revenue Growth (yoy)8.80%
Gross Profit (ttm)1.37B
EBITDA 477.51M
Net Income Avi to Common (ttm)239.67M
Diluted EPS (ttm)3.61
Quarterly Earnings Growth (yoy)5,452.30%

Balance Sheet

Total Cash (mrq)181.77M
Total Cash Per Share (mrq)2.87
Total Debt (mrq)1.6B
Total Debt/Equity (mrq)168.64
Current Ratio (mrq)1.10
Book Value Per Share (mrq)14.97

Cash Flow Statement

Operating Cash Flow (ttm)197.21M
Levered Free Cash Flow (ttm)108.32M